XML 17 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 6 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Operating Activities:    
Net income (loss) $ (160.6) $ 187.4
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 81.1 79.3
Amortization of films and television programs and program rights 723.2 764.6
Interest on dissenting shareholders' liability 32.6 27.2
Amortization of debt discount and financing costs 6.0 7.5
Non-cash share-based compensation 30.2 47.4
Other non-cash items 12.1 3.9
Shareholder litigation settlements [1] 114.1 0.0
Loss on extinguishment of debt 0.0 18.0
Equity interests loss 17.8 21.0
Loss (gain) on investments 37.0 (201.0)
Deferred income taxes (benefit) (40.9) 16.2
Changes in operating assets and liabilities:    
Accounts receivable, net and other assets 172.7 131.6
Investment in films and television programs and program rights, net (697.1) (680.7)
Accounts payable and accrued liabilities (65.3) (197.7)
Participations and residuals (24.1) 20.9
Film obligations (12.4) 25.7
Deferred revenue 43.5 65.3
Net Cash Flows Provided By Operating Activities 269.9 336.6
Investing Activities:    
Proceeds from the sale of equity method investee, net of transaction costs 0.0 393.7
Investment in equity method investees (16.2) (29.3)
Business acquisitions, net of cash acquired of $5.5 (see Note 2) (77.3) 0.0
Increase in loans receivable (5.8) 0.0
Capital expenditures (21.6) (21.3)
Net Cash Flows Provided By (Used In) Investing Activities (120.9) 343.1
Financing Activities:    
Debt - borrowings 2,069.5 115.0
Debt - repayments (2,144.8) (818.0)
Production loans - borrowings 154.5 169.7
Production loans - repayments (189.7) (251.6)
Dividends paid (38.2) 0.0
Distributions to noncontrolling interest (1.5) (4.6)
Exercise of stock options 1.8 22.4
Tax withholding required on equity awards (4.0) (8.5)
Net Cash Flows Used In Financing Activities (152.4) (775.6)
Net Change In Cash, Cash Equivalents and Restricted Cash (3.4) (95.9)
Foreign Exchange Effects on Cash, Cash Equivalents and Restricted Cash (2.4) (2.9)
Cash, Cash Equivalents and Restricted Cash - Beginning Of Period 378.1 324.7
Cash and Cash Equivalents - End Of Period $ 372.3 $ 225.9
[1] Shareholder litigation settlements of $114.1 million in the three and six months ended September 30, 2018 includes the following: (i) $54.8 million for the net expense recorded for the settlement of the Fiduciary Litigation (representing the settlement amount of $92.5 million, which the Company has included in accounts payable and accrued liabilities in the unaudited condensed consolidated balance sheet, net of aggregate insurance reimbursement of $37.8 million, which amount the Company has recorded a receivable included in the "other current assets" line item in the unaudited condensed consolidated balance sheet as of September 30, 2018) and (ii) $59.3 million related to the Appraisal Litigation, representing the amount by which the settlement amount of approximately $961 million exceeds the previously accrued $901.9 million dissenting shareholders' liability, before considering the settlement (i.e., dissenting shareholders' liability plus accrued interest through September 30, 2018). See Note 16.